Fritextsökning
Innehållstyper
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
Konkreta åtgärder av stor vikt för life science-strategi
När bransch och vård samlades på fredagen för att gemensamt ta fram en life science-strategi stod det klart att åtgärderna måste vara konkreta för att det verkl...
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Hållbar magnetloppa utan porer
Spinfinity är en loppa för magnetomrörare från företaget Bel-Art, som uppges vara utan porer och ha en livslängd på upp till tre gånger längre än en vanlig loppa.
-
Cell incubator with built-in microscope
InCu-view live is an incubator from Sanyo for cell or embryo culture with documentation functionality.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Avföring mot resistens
Donerad avföring kan användas för att behandla infektioner med resistenta bakterier i tarmen.
-
Fler avtal bygger på riskdelning
Kreativa avtal mellan landsting och läkemedelsföretag blir allt vanligare. Men det som skulle kunna handla om ett nytt sätt att värdera nyttan för patienten bli...
-
Småbolagen vinnare vid uppköp
De mindre biotech-bolagen är de stora vinnarna när patentklyftan närmar sig. Ny forskning visar att Big Pharma pungar ut med betydligt högre budpremier än bolag...
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
"Utan konkreta förslag blir åtgärderna diffusa"
”Det är synd att det många gånger tar stopp i mejlkorgen.”
-
Medivir rusar efter nyhet från USA
Amerikanska Gileads preparat behöver en antiviral substans för att vara effektiv mot hepatit C. "För oss är det bra", säger Rein Piir på Medivir.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Enjoy Stockholm - the capital of Scandinavia
Welcome to Stockholm! Built on 14 islands, you are never far from the water in the capital of Sweden. Stockholm offers a wide range of museums, theaters, and at...
-
An industry emerging from crisis
"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "
-
Printing sensors for biological samples
Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
BREAKING